The agency announced on December 20,2021, that the FDA has approved the first long-lasting injectable drug Apretude to be used as an unveiling prevention against HIV. Daily intake of Truvada and Discovy (both are the existing pills to prevent HIV) has been shown to lower the risk of HIV by 99%. But the injectable drug Apretude which is an alternative to these pills, given every two mo... https://www.coherentmarketinsights.com/news/first-injectable-hiv-drug-get-approval-by-fda-620